Cargando…

Site-specific glycan analysis of the SARS-CoV-2 spike

The emergence of the betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), represents a considerable threat to global human health. Vaccine development is focused on the principal target of the humoral immune respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Yasunori, Allen, Joel D., Wrapp, Daniel, McLellan, Jason S., Crispin, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2020
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199903/ https://www.ncbi.nlm.nih.gov/pubmed/32366695 http://dx.doi.org/10.1126/science.abb9983

Ejemplares similares

Site-specific analysis of the SARS-CoV-2 glycan shield
por: Watanabe, Yasunori, et al.
Publicado: (2020)

Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition
por: Allen, Joel D., et al.
Publicado: (2021)

Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics
por: Newby, Maddy L., et al.
Publicado: (2023)

Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
por: Casalino, Lorenzo, et al.
Publicado: (2020)

Beyond Shielding: The Roles of Glycans in SARS-CoV-2 Spike Protein
por: Casalino, Lorenzo, et al.
Publicado: (2020)

Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike Mimetic
por: Chawla, Himanshi, et al.
Publicado: (2022)

A glycan gate controls opening of the SARS-CoV-2 spike protein
por: Sztain, Terra, et al.
Publicado: (2021)

A glycan gate controls opening of the SARS-CoV-2 spike protein
por: Sztain, Terra, et al.
Publicado: (2021)

Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation
por: Allen, Joel D., et al.
Publicado: (2021)

The 3.1-Angstrom Cryo-electron Microscopy Structure of the Porcine Epidemic Diarrhea Virus Spike Protein in the Prefusion Conformation
por: Wrapp, Daniel, et al.
Publicado: (2019)

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
por: Watanabe, Yasunori, et al.
Publicado: (2020)

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
por: Allen, Joel D., et al.
Publicado: (2023)

The diversity of the glycan shield of sarbecoviruses closely related to SARS-CoV-2
por: Allen, Joel D., et al.
Publicado: (2022)

Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation
por: Wrapp, Daniel, et al.
Publicado: (2020)

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
por: Wrapp, Daniel, et al.
Publicado: (2020)

Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures
por: Melero, Roberto, et al.
Publicado: (2020)

Continuous flexibility analysis of SARS-CoV-2 Spike prefusion structures
por: Melero, Roberto, et al.
Publicado: (2020)

Binding of the SARS-CoV-2 spike protein to glycans
por: Hao, Wei, et al.
Publicado: (2021)

The roles of glycans in the SARS-CoV-2 spike protein
por: Casalino, Lorenzo, et al.
Publicado: (2022)

Suppression of O-Linked Glycosylation of the SARS-CoV-2 Spike by Quaternary Structural Restraints
por: Eldrid, Charles F. S., et al.
Publicado: (2021)

Concerted hinge motions in SARS-CoV-2 spike modulated by glycan-glycan and glycan-lipid interactions
por: Kapoor, Karan, et al.
Publicado: (2022)

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
por: Hsieh, Ching-Lin, et al.
Publicado: (2020)

Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes
por: Hsieh, Ching-Lin, et al.
Publicado: (2020)

Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry
por: Guseman, Alex J., et al.
Publicado: (2022)

Targeting spike glycans to inhibit SARS-CoV2 viral entry
por: Guseman, Alex J., et al.
Publicado: (2023)

Global site-specific analysis of glycoprotein N-glycan processing
por: Cao, Liwei, et al.
Publicado: (2018)

Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation
por: Henderson, Rory, et al.
Publicado: (2020)

Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein
por: Wang, Yan, et al.
Publicado: (2021)

Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production
por: Zhao, Xiaohui, et al.
Publicado: (2021)

Characterization and Function of Glycans on the Spike Proteins of SARS-CoV-2 Variants of Concern
por: Zheng, Luping, et al.
Publicado: (2022)

Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein
por: Wec, Anna Z., et al.
Publicado: (2020)

Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition
por: Grant, Oliver C., et al.
Publicado: (2020)

Ensemble-based, glycan-dependent epitope analysis of SARS-CoV-2 spike protein
por: Chen, Tianle, et al.
Publicado: (2022)

SARS-CoV-2 spike binding to ACE2 is stronger and longer ranged with glycans
por: Huang, Yihan, et al.
Publicado: (2022)

Abstract 1509: Targeting Spike Glycans to Inhibit SARS-CoV-2 Viral Entry
por: Guseman, Alex, et al.
Publicado: (2023)

The SARS-CoV-2 spike protein reversibly samples an open-trimer conformation exposing novel epitopes
por: Shoemaker, Sophie R., et al.
Publicado: (2022)

Stabilized SARS-CoV-2 spike S2 immunogens designed using insights from enhanced sampling molecular dynamics simulations
por: Nuqui, Xandra, et al.
Publicado: (2023)

Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein
por: Wintjens, René, et al.
Publicado: (2020)

Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition
por: Grant, Oliver C., et al.
Publicado: (2020)

N-Glycosylation Network Construction and Analysis to Modify Glycans on the Spike (S) Glycoprotein of SARS-CoV-2
por: Krishnan, Sridevi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p249c39gr2grbkf7j855tf5ofa